Back to Search
JASON FRISCHER, MD
MD
Pediatric Surgery Physician
NPI: 1760640692IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pediatric Surgery PhysicianPrimary
Surgery — Pediatric Surgery
Code: 2086S0120X
52205(TN)35.092167(OH)47884(KY)
CMS Specialties
PrimaryGENERAL SURGERY
Additional
PEDIATRIC MEDICINE
Education
OTHER
Class of 1999
Research & Publications (18)
Gastric tube-pericardial fistula: a remote complication of esophageal replacement for long gap esophageal atresia.
PMID 19573675·J Pediatr Surg·2009
5-case
The relation between inflammation and neurodegeneration in multiple sclerosis brains.
PMID 19339255·Brain·2009
8-other
Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation.
PMID 18234958·Mol Cancer Res·2008
7-preclinical
Long-term seizure control after resection of supratentorial cavernomas: a retrospective single-center study in 53 patients.
PMID 19005379·Neurosurgery·2008
8-other
Cerebral cavernous malformations: congruency of histopathological features with the current clinical definition.
PMID 17986498·J Neurol Neurosurg Psychiatry·2008
8-other
Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling.
PMID 16618763·Cancer Res·2006
7-preclinical
Extracorporeal membrane oxygenation in pediatric cardiac transplantation.
PMID 15991195·J Pediatr Surg·2005
8-other
Effects of potent VEGF blockade on experimental Wilms tumor and its persisting vasculature.
PMID 15289855·Int J Oncol·2004
7-preclinical
TNP-470 promotes initial vascular sprouting in xenograft tumors.
PMID 15026554·Mol Cancer Ther·2004
7-preclinical
Human epidermal growth factor receptor signaling contributes to tumor growth via angiogenesis in her2/neu-expressing experimental Wilms' tumor.
PMID 14614702·J Pediatr Surg·2003
4-observational
Thalidomide is anti-angiogenic in a xenograft model of neuroblastoma.
PMID 14612937·Int J Oncol·2003
7-preclinical
Regression of established tumors and metastases by potent vascular endothelial growth factor blockade.
PMID 12805568·Proc Natl Acad Sci U S A·2003
7-preclinical
Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.
PMID 12632340·J Pediatr Surg·2003
7-preclinical
Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma.
PMID 12177446·Proc Natl Acad Sci U S A·2002
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 3333 BURNET AVE
CINCINNATI, OH 45229 - Phone
- (513) 636-4371
Quick Facts
- NPI
- 1760640692
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 27
- Publications
- 18
Are you this provider?
Claim Your Profile